Ixtlan BioScience

Psilocybin-based Treatments for Brain Pathologies

Health Tech & Life Sciences
Non Active, Aug 2024 ceased to operate
Pre-Funding Caesarea, Israel Founded 2020
LinkedIn
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2020
Headcount
4
HQ
Caesarea, Israel
Sector
Health Tech & Life Sciences

About

Ixtlan Bioscience is focused on developing a psilocybin-based treatment for Alzheimer's disease and other brain pathologies. The company is devoted to defining and utilizing psilocybin micro-dosing in order to find a new and better class of safe and accessible mental health therapies to slow down the progression of Alzheimer's and dementia diseases.

Q&A

What is Ixtlan BioScience's primary focus?
Ixtlan BioScience is focused on developing psilocybin-based treatments for Alzheimer's disease and other brain pathologies.
What is the current operational status of Ixtlan BioScience?
Ixtlan BioScience is currently inactive and ceased to operate in August 2024.
When was Ixtlan BioScience founded?
Ixtlan BioScience was founded in April 2020.
Where is Ixtlan BioScience headquartered?
Ixtlan BioScience is headquartered in Caesarea, Center District, Israel.
How many employees does Ixtlan BioScience have?
Ixtlan BioScience has 1-10 employees.
What is Ixtlan BioScience's current funding stage?
Ixtlan BioScience is in the Pre-Funding stage.
What sectors does Ixtlan BioScience operate in?
Ixtlan BioScience operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, and Biomaterials & Tissue Engineering.
What is Ixtlan BioScience's product stage?
Ixtlan BioScience's product is in the R&D stage.

Team · 4

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗
Founder · Co-founder & Scientific Advisor
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiomaterials & Tissue Engineering
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

Verified

Tags

patent-pendinghome-carebiopharmaceuticalalzheimers-diseasebiotechnologydata-analyticspharmaceuticalsnutraceuticalsbrain-disordermental-health
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)